This company has been marked as potentially delisted and may not be actively trading. Brookline Capital Acquisition (BCAC) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Brookline Capital Acquisition Short Interest DataBrookline Capital Acquisition (BCAC) has a short interest of 6,800 shares, representing 0.11% of the float (the number of shares available for trading by the public). This marks a -8.11% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 39,682 shares to cover all short positions.Current Short Interest6,800 sharesPrevious Short Interest7,400 sharesChange Vs. Previous Month-8.11%Dollar Volume Sold Short$69.29 thousandShort Interest Ratio0.3 Days to CoverLast Record DateJuly 15, 2022Outstanding Shares6,746,000 sharesFloat Size6,180,000 sharesShort Percent of Float0.11%Today's Trading Volume29,998 sharesAverage Trading Volume39,682 sharesToday's Volume Vs. Average76% Short Selling Brookline Capital Acquisition? Sign up to receive the latest short interest report for Brookline Capital Acquisition and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCAC Short Interest Over TimeBCAC Days to Cover Over TimeBCAC Percentage of Float Shorted Over Time Brookline Capital Acquisition Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20226,800 shares $69.29 thousand -8.1%0.1%0.3 $10.19 6/30/20227,400 shares $75.18 thousand +23.3%0.1%0.2 $10.16 6/15/20226,000 shares $60.79 thousand -98.3%0.1%0.1 $10.13 5/31/2022349,400 shares $3.54 million +2,861.0%5.6%6.8 $10.15 5/15/202211,800 shares $119.30 thousand -57.9%0.2%0.2 $10.11 4/30/202228,000 shares $283.22 thousand +28.4%0.4%0.6 $10.12 4/15/202221,800 shares $220.18 thousand +3.3%0.3%0.5 $10.10 3/31/202221,100 shares $212.69 thousand +49.7%N/A0.7 $10.08 3/15/202214,100 shares $141.71 thousand +683.3%N/A0.5 $10.05 2/28/20221,800 shares $18.07 thousand -74.7%0.0%0.1 $10.04 Get the Latest News and Ratings for BCAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Brookline Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter. 2/15/20227,100 shares $71.14 thousand +24.6%N/A0.6 $10.02 1/31/20225,700 shares $57.06 thousand +62.9%N/A0.4 $10.01 1/15/20223,500 shares $35.07 thousand +9.4%N/A0.3 $10.02 12/31/20213,200 shares $32.03 thousand +100.0%N/A0.3 $10.01 12/15/20211,600 shares $15.98 thousand -88.1%N/A0.2 $9.99 11/30/202113,400 shares $133.33 thousand +243.6%N/A1.4 $9.95 11/15/20213,900 shares $38.81 thousand -90.1%N/A0.4 $9.95 10/29/202139,500 shares $393.82 thousand +1,480.0%N/A4.1 $9.97 10/15/20212,500 shares $24.85 thousand -24.2%N/A0.3 $9.94 9/30/20213,300 shares $32.84 thousand -36.5%N/A0.3 $9.95 9/15/20215,200 shares $51.69 thousand +62.5%N/A0.5 $9.94 8/31/20213,200 shares $31.68 thousand -40.7%N/A0.3 $9.90 8/13/20215,400 shares $53.30 thousand No ChangeN/A0.6 $9.87 BCAC Short Interest - Frequently Asked Questions What is Brookline Capital Acquisition's current short interest? Short interest is the volume of Brookline Capital Acquisition shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 6,800 shares of BCAC short. 0.11% of Brookline Capital Acquisition's shares are currently sold short. Learn More on Brookline Capital Acquisition's current short interest. What is a good short interest percentage for Brookline Capital Acquisition? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.11% of Brookline Capital Acquisition's floating shares are currently sold short. Is Brookline Capital Acquisition's short interest increasing or decreasing? Brookline Capital Acquisition saw a drop in short interest in July. As of July 15th, there was short interest totaling 6,800 shares, a drop of 8.1% from the previous total of 7,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Brookline Capital Acquisition's float size? Brookline Capital Acquisition currently has issued a total of 6,746,000 shares. Some of Brookline Capital Acquisition's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Brookline Capital Acquisition currently has a public float of 6,180,000 shares. How does Brookline Capital Acquisition's short interest compare to its competitors? 0.11% of Brookline Capital Acquisition's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Brookline Capital Acquisition: Achilles Therapeutics plc (1.26%), bluebird bio, Inc. (2.91%), ZIVO Bioscience, Inc. (1.77%), Cyclo Therapeutics, Inc. (3.55%), Finch Therapeutics Group, Inc. (0.10%), NKGen Biotech, Inc. (1.02%), AlloVir, Inc. (2.56%), Chromocell Therapeutics Co. (8.70%), Calidi Biotherapeutics, Inc. (1.23%), CEL-SCI Co. (5.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.50 billion), KLA Corporation ($2.53 billion), Lucid Group, Inc. ($2.50 billion), T. Rowe Price Group, Inc. ($1.91 billion), Williams-Sonoma, Inc. ($1.78 billion), Coinbase Global, Inc. ($1.78 billion), HP Inc. ($1.75 billion), Rivian Automotive, Inc. ($1.70 billion), Lumen Technologies, Inc. ($1.58 billion), and Chesapeake Energy Co. ($1.45 billion). View all of the most shorted stocks. What does it mean to sell short Brookline Capital Acquisition stock? Short selling BCAC is an investing strategy that aims to generate trading profit from Brookline Capital Acquisition as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Brookline Capital Acquisition? A short squeeze for Brookline Capital Acquisition occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCAC, which in turn drives the price of the stock up even further. How often is Brookline Capital Acquisition's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCAC, twice per month. The most recent reporting period available is July, 15 2022. More Short Interest Resources from MarketBeat Related Companies ACHL Short Interest Data BLUE Short Interest Data ZIVO Short Interest Data CYTH Short Interest Data FNCH Short Interest Data NKGN Short Interest Data ALVR Short Interest Data CHRO Short Interest Data CLDI Short Interest Data CVM Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCAC) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brookline Capital Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brookline Capital Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.